NLRP3 and COVID-19: The NLRP3 inflammasome activation in lipopolysaccharide-primed macrophages was shown to be induced by SARS-CoV 3a [42]; AGEs may escalate COVID-19 severity in elderly people by hindering NLRP3 inflammasome-mediated innate immune responses during the early stages of viral infection [43].